Event Date/Time: Oct 26, 2009
End Date/Time: Oct 28, 2009
Optimizing Efficiencies in Polymorphism & Crystallization to Improve Solubility, Increase Bioavailability & Speed Drug Development of Patentable Solids. IQPCâ€™s 8th Polymorphism & Crystallization Scientific Forum is aimed at helping companies to lower costs, increase efficiency and cover a broad range of successful technical case studies on crystal nucleation and polymorphism â€“ a major issue and area of drug development for the pharmaceutical and biotech industry. The Forum will address key areas, including: Novel analytical techniques and solutions, Litigating Polymorph and Pharmaceutical Patent Cases, New Developments in Scale-Up and QbD to Ensure Control, Pharmaceutical Co-Crystals, and Polymorphic Screening and Characterization of API A, API B and Co-Crystals. The Use of Solvate Formation as a Tool to Optimize Purification via Crystallization, Current Capabilities in Technologies to Effectively Analyze Impurities in Crystal Forms, and Perspective on Polymorphic Forms in Abbreviated New Drug Applications (ANDAs). Challenges and Difficulties in Polymorphism, Polymorphism as a Tool for Life Cycle Extension, Practical Uses of Amorphous APIâ€™s - Features and Stability, Materials Sciences and Crystallization - The Interface Between Drug Substance and Drug Product. Crystal Nucleation and Polymorphism, and Implementing continuous crystallization successfully are all topics of interest.